The SARS-CoV-2 pandemic has adversely affected people’s health around the world, and many have died due to complications from conditions such as high blood pressure and type 2 diabetes mellitus. Remote testing could provide an innovative solution.
As a result of a genetic predisposition, Black, Asian and Minority Ethnic (BAME) people are more likely to have high blood pressure (HBP) and type 2 diabetes mellitus (T2DM) compared to Caucasians, and are more susceptible to develop COVID-19 disease as a result of these health conditions,
The UK has four million people with T2DM. Africans and Afro-Caribbeans are three times more likely and South Asians six times more likely to develop T2DM. In addition, 50% of T2DM sufferers have high blood pressure, and T2DM is three or four times more likely to occur in Black people of African/Afro-Caribbean descent than white people.
Health issues related to HBP and T2DM cost the NHS a staggering £2.1 billion every year. Every 10 years, poor monitoring of these diseases results in the loss of 7000 quality-adjusted UK life years. A sustainable solution is paramount as these losses are avoidable.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.